EMPLOYMENT AGREEMENTAgreement • March 27th, 2012 • TEKMIRA PHARMACEUTICALS Corp • Pharmaceutical preparations • British Columbia
LOAN AGREEMENTLoan Agreement • March 27th, 2012 • TEKMIRA PHARMACEUTICALS Corp • Pharmaceutical preparations
THIS LOAN AGREEMENT (this “Agreement”) dated as of December 21, 2011 (the “Effective Date”) between SILICON VALLEY BANK, a California corporation (“Bank”), and TEKMIRA PHARMACEUTICALS CORPORATION, a British Columbia corporation (“Parent”) and PROTIVA BIOTHERAPEUTICS INC., a British Columbia corporation (each a “Co-Borrower” and collectively “Co-Borrowers”), provides the terms on which Bank shall lend to Co-Borrowers and Co-Borrowers shall repay Bank. The parties agree as follows:
LICENSE AND COLLABORATION AGREEMENT BETWEEN PROTIVA BIOTHERAPEUTICS INC. AND HALO-BIO RNAI THERAPEUTICS, INC.License and Collaboration Agreement • March 27th, 2012 • TEKMIRA PHARMACEUTICALS Corp • Pharmaceutical preparations • New York
THIS LICENSE AND COLLABORATION AGREEMENT is dated as of August 24th, 2011 (the “Effective Date”) between HALO-BIO RNAI THERAPEUTICS, INC. (“Halo-Bio”), a Washington corporation having a principal place of business at 4111 E. Madison, Box 140, Seattle, Washington 98112, U.S.A. and PROTIVA BIOTHERAPEUTICS INC. (“Protiva”), a Canadian corporation and wholly-owned subsidiary of TEKMIRA PHARMACEUTICALS CORPORATION (“Tekmira”), having a principal place of business at 100-8900 Glenlyon Parkway, Burnaby, B.C., Canada V5J 5J8.
